APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biosimilars Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biosimilars Drug Industry Growth and Trends Forecast to 2032

20 December 2025123 pages

Choose your research edition.

Industry ResearchBiosimilars Drug Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Biosimilars Drug Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Biosimilars Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biosimilars Drug Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Biosimilars Drug Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

According to APO Research, the global Biosimilars Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biosimilars Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biosimilars Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biosimilars Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Biosimilars Drug market include Sanofi, Qilu Pharmaceutical, Novartis, Eli Lilly, Pfizer, Zhejiang Hisun, Wockhardt, United Laboratory and Tonghua Dongbao, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biosimilars Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biosimilars Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biosimilars Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biosimilars Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Biosimilars Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biosimilars Drug Market by Company

Sanofi

Qilu Pharmaceutical

Novartis

Eli Lilly

Pfizer

Zhejiang Hisun

Wockhardt

United Laboratory

Tonghua Dongbao

Shanghai Henlius

Luye Pharma

Jiangsu Hengrui

Innovent Biologics

Geropharm

Gan&Lee

Dr Reddy’s

Celltrion

Celgen Biopharma

Bio-Thera

Biocon

3SBIO

Biosimilars Drug Segment by Type

Monoclonal Antibodies

Insulin

Others

Biosimilars Drug Segment by Application

Hospital

Retail Pharmacy

Other

Biosimilars Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biosimilars Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biosimilars Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biosimilars Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Biosimilars Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Biosimilars Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Biosimilars Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Biosimilars Drug Market Share by Region (2021-2026) Table 4. Global Biosimilars Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Biosimilars Drug Market Share by Region (2027-2032) Table 6. Global Biosimilars Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Biosimilars Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Biosimilars Drug Market Size Share by Type (2021-2026) Table 9. Global Biosimilars Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Biosimilars Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Biosimilars Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Biosimilars Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Biosimilars Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Biosimilars Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Biosimilars Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Biosimilars Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Biosimilars Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Biosimilars Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Biosimilars Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Biosimilars Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Biosimilars Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Biosimilars Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Biosimilars Drug Market Size Share by Application (2021-2026) Table 24. Global Biosimilars Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Biosimilars Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Biosimilars Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Biosimilars Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Biosimilars Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Biosimilars Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Biosimilars Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Biosimilars Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Biosimilars Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Biosimilars Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Biosimilars Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Biosimilars Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Biosimilars Drug Industry Trends Table 37. Biosimilars Drug Industry Drivers Table 38. Biosimilars Drug Industry Opportunities and Challenges Table 39. Biosimilars Drug Industry Restraints Table 40. Global Biosimilars Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Biosimilars Drug Revenue Market Share by Company (2021-2026) Table 42. Global Biosimilars Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Biosimilars Drug Key Company Headquarters & Area Served Table 44. Global Biosimilars Drug Company, Product Type & Application Table 45. Global Biosimilars Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Biosimilars Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Sanofi Company Information Table 49. Sanofi Business Overview Table 50. Sanofi Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Sanofi Biosimilars Drug Product Portfolio Table 52. Sanofi Recent Development Table 53. Qilu Pharmaceutical Company Information Table 54. Qilu Pharmaceutical Business Overview Table 55. Qilu Pharmaceutical Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Qilu Pharmaceutical Biosimilars Drug Product Portfolio Table 57. Qilu Pharmaceutical Recent Development Table 58. Novartis Company Information Table 59. Novartis Business Overview Table 60. Novartis Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Novartis Biosimilars Drug Product Portfolio Table 62. Novartis Recent Development Table 63. Eli Lilly Company Information Table 64. Eli Lilly Business Overview Table 65. Eli Lilly Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Eli Lilly Biosimilars Drug Product Portfolio Table 67. Eli Lilly Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Pfizer Biosimilars Drug Product Portfolio Table 72. Pfizer Recent Development Table 73. Zhejiang Hisun Company Information Table 74. Zhejiang Hisun Business Overview Table 75. Zhejiang Hisun Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Zhejiang Hisun Biosimilars Drug Product Portfolio Table 77. Zhejiang Hisun Recent Development Table 78. Wockhardt Company Information Table 79. Wockhardt Business Overview Table 80. Wockhardt Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Wockhardt Biosimilars Drug Product Portfolio Table 82. Wockhardt Recent Development Table 83. United Laboratory Company Information Table 84. United Laboratory Business Overview Table 85. United Laboratory Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. United Laboratory Biosimilars Drug Product Portfolio Table 87. United Laboratory Recent Development Table 88. Tonghua Dongbao Company Information Table 89. Tonghua Dongbao Business Overview Table 90. Tonghua Dongbao Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Tonghua Dongbao Biosimilars Drug Product Portfolio Table 92. Tonghua Dongbao Recent Development Table 93. Shanghai Henlius Company Information Table 94. Shanghai Henlius Business Overview Table 95. Shanghai Henlius Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Shanghai Henlius Biosimilars Drug Product Portfolio Table 97. Shanghai Henlius Recent Development Table 98. Luye Pharma Company Information Table 99. Luye Pharma Business Overview Table 100. Luye Pharma Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Luye Pharma Biosimilars Drug Product Portfolio Table 102. Luye Pharma Recent Development Table 103. Jiangsu Hengrui Company Information Table 104. Jiangsu Hengrui Business Overview Table 105. Jiangsu Hengrui Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Jiangsu Hengrui Biosimilars Drug Product Portfolio Table 107. Jiangsu Hengrui Recent Development Table 108. Innovent Biologics Company Information Table 109. Innovent Biologics Business Overview Table 110. Innovent Biologics Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Innovent Biologics Biosimilars Drug Product Portfolio Table 112. Innovent Biologics Recent Development Table 113. Geropharm Company Information Table 114. Geropharm Business Overview Table 115. Geropharm Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Geropharm Biosimilars Drug Product Portfolio Table 117. Geropharm Recent Development Table 118. Gan&Lee Company Information Table 119. Gan&Lee Business Overview Table 120. Gan&Lee Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Gan&Lee Biosimilars Drug Product Portfolio Table 122. Gan&Lee Recent Development Table 123. Dr Reddy’s Company Information Table 124. Dr Reddy’s Business Overview Table 125. Dr Reddy’s Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Dr Reddy’s Biosimilars Drug Product Portfolio Table 127. Dr Reddy’s Recent Development Table 128. Celltrion Company Information Table 129. Celltrion Business Overview Table 130. Celltrion Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Celltrion Biosimilars Drug Product Portfolio Table 132. Celltrion Recent Development Table 133. Celgen Biopharma Company Information Table 134. Celgen Biopharma Business Overview Table 135. Celgen Biopharma Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Celgen Biopharma Biosimilars Drug Product Portfolio Table 137. Celgen Biopharma Recent Development Table 138. Bio-Thera Company Information Table 139. Bio-Thera Business Overview Table 140. Bio-Thera Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Bio-Thera Biosimilars Drug Product Portfolio Table 142. Bio-Thera Recent Development Table 143. Biocon Company Information Table 144. Biocon Business Overview Table 145. Biocon Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Biocon Biosimilars Drug Product Portfolio Table 147. Biocon Recent Development Table 148. 3SBIO Company Information Table 149. 3SBIO Business Overview Table 150. 3SBIO Biosimilars Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. 3SBIO Biosimilars Drug Product Portfolio Table 152. 3SBIO Recent Development Table 153. North America Biosimilars Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Biosimilars Drug Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Biosimilars Drug Market Share by Country (2021-2026) Table 156. North America Biosimilars Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Biosimilars Drug Market Share Forecast by Country (2027-2032) Table 158. Europe Biosimilars Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Biosimilars Drug Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Biosimilars Drug Market Share by Country (2021-2026) Table 161. Europe Biosimilars Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Biosimilars Drug Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Biosimilars Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Biosimilars Drug Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Biosimilars Drug Market Share by Country (2021-2026) Table 166. Asia-Pacific Biosimilars Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Biosimilars Drug Market Share Forecast by Country (2027-2032) Table 168. Latin America Biosimilars Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Biosimilars Drug Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Biosimilars Drug Market Share by Country (2021-2026) Table 171. Latin America Biosimilars Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Biosimilars Drug Market Share Forecast by Country (2027-2032) Table 173. Middle East & Africa Biosimilars Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East & Africa Biosimilars Drug Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East & Africa Biosimilars Drug Market Share by Country (2021-2026) Table 176. Middle East & Africa Biosimilars Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East & Africa Biosimilars Drug Market Share Forecast by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Biosimilars Drug Product Image Figure 3. Global Biosimilars Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Biosimilars Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Biosimilars Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Biosimilars Drug Market Share by Region (2021-2032) Figure 7. North America Biosimilars Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Biosimilars Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Biosimilars Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Biosimilars Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Biosimilars Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Monoclonal Antibodies Image Figure 13. Global Monoclonal Antibodies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Insulin Image Figure 15. Global Insulin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Biosimilars Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Biosimilars Drug Market Share by Type 2025 VS 2032 Figure 20. North America Biosimilars Drug Market Size Share by Type (2021-2032) Figure 21. Europe Biosimilars Drug Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Biosimilars Drug Market Size Share by Type (2021-2032) Figure 23. Latin America Biosimilars Drug Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Biosimilars Drug Market Size Share by Type (2021-2032) Figure 25. Hospital Image Figure 26. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Retail Pharmacy Image Figure 28. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Other Image Figure 30. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Biosimilars Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Biosimilars Drug Market Share by Application 2025 VS 2032 Figure 33. North America Biosimilars Drug Market Size Share by Application (2021-2032) Figure 34. Europe Biosimilars Drug Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Biosimilars Drug Market Size Share by Application (2021-2032) Figure 36. Latin America Biosimilars Drug Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Biosimilars Drug Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Biosimilars Drug Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Biosimilars Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Biosimilars Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Biosimilars Drug Market Share by Country (2021-2032) Figure 43. Europe Biosimilars Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Biosimilars Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Biosimilars Drug Market Share by Country (2021-2032) Figure 46. Asia-Pacific Biosimilars Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Biosimilars Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Biosimilars Drug Market Share by Country (2021-2032) Figure 49. Latin America Biosimilars Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Biosimilars Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Biosimilars Drug Market Share by Country (2021-2032) Figure 52. Middle East & Africa Biosimilars Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Biosimilars Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Biosimilars Drug Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies
  • Insulin
  • Others
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Sanofi
  • Qilu Pharmaceutical
  • Novartis
  • Eli Lilly
  • Pfizer
  • Zhejiang Hisun
  • Wockhardt
  • United Laboratory
  • Tonghua Dongbao
  • Shanghai Henlius
  • Luye Pharma
  • Jiangsu Hengrui
  • Innovent Biologics
  • Geropharm
  • Gan&Lee
  • Dr Reddy’s
  • Celltrion
  • Celgen Biopharma
  • Bio-Thera
  • Biocon
  • 3SBIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Biosimilars Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Biosimilars Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Biosimilars Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Biosimilars Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Biosimilars Drug Market Size (2021-2032)
  8. 1.5.1 North America Biosimilars Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Biosimilars Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Biosimilars Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Biosimilars Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Biosimilars Drug Market Size Growth Rate (2021-2032)
2 Biosimilars Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Monoclonal Antibodies
  3. 2.1.2 Insulin
  4. 2.1.3 Others
  5. 2.2 Global Biosimilars Drug Market Size by Type
  6. 2.2.1 Global Biosimilars Drug Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Biosimilars Drug Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Biosimilars Drug Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Biosimilars Drug Market Size by Regions
  10. 2.3.1 North America Biosimilars Drug Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Biosimilars Drug Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Biosimilars Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Biosimilars Drug Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Biosimilars Drug Market Size Breakdown by Type (2021-2026)
3 Biosimilars Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Retail Pharmacy
  4. 3.1.3 Other
  5. 3.2 Global Biosimilars Drug Market Size by Application
  6. 3.2.1 Global Biosimilars Drug Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Biosimilars Drug Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Biosimilars Drug Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Biosimilars Drug Market Size by Regions
  10. 3.3.1 North America Biosimilars Drug Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Biosimilars Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Biosimilars Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Biosimilars Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Biosimilars Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Biosimilars Drug Industry Trends
  2. 4.2 Biosimilars Drug Industry Drivers
  3. 4.3 Biosimilars Drug Industry Opportunities and Challenges
  4. 4.4 Biosimilars Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Biosimilars Drug Revenue (2021-2026)
  2. 5.2 Global Biosimilars Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Biosimilars Drug Key Company Headquarters & Area Served
  4. 5.4 Global Biosimilars Drug Company, Product Type & Application
  5. 5.5 Global Biosimilars Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Biosimilars Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Biosimilars Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Biosimilars Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Biosimilars Drug Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Qilu Pharmaceutical
  8. 6.2.1 Qilu Pharmaceutical Company Information
  9. 6.2.2 Qilu Pharmaceutical Business Overview
  10. 6.2.3 Qilu Pharmaceutical Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Qilu Pharmaceutical Biosimilars Drug Product Portfolio
  12. 6.2.5 Qilu Pharmaceutical Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Biosimilars Drug Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Eli Lilly
  20. 6.4.1 Eli Lilly Company Information
  21. 6.4.2 Eli Lilly Business Overview
  22. 6.4.3 Eli Lilly Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Eli Lilly Biosimilars Drug Product Portfolio
  24. 6.4.5 Eli Lilly Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Biosimilars Drug Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Zhejiang Hisun
  32. 6.6.1 Zhejiang Hisun Company Information
  33. 6.6.2 Zhejiang Hisun Business Overview
  34. 6.6.3 Zhejiang Hisun Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Zhejiang Hisun Biosimilars Drug Product Portfolio
  36. 6.6.5 Zhejiang Hisun Recent Developments
  37. 6.7 Wockhardt
  38. 6.7.1 Wockhardt Company Information
  39. 6.7.2 Wockhardt Business Overview
  40. 6.7.3 Wockhardt Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Wockhardt Biosimilars Drug Product Portfolio
  42. 6.7.5 Wockhardt Recent Developments
  43. 6.8 United Laboratory
  44. 6.8.1 United Laboratory Company Information
  45. 6.8.2 United Laboratory Business Overview
  46. 6.8.3 United Laboratory Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 United Laboratory Biosimilars Drug Product Portfolio
  48. 6.8.5 United Laboratory Recent Developments
  49. 6.9 Tonghua Dongbao
  50. 6.9.1 Tonghua Dongbao Company Information
  51. 6.9.2 Tonghua Dongbao Business Overview
  52. 6.9.3 Tonghua Dongbao Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Tonghua Dongbao Biosimilars Drug Product Portfolio
  54. 6.9.5 Tonghua Dongbao Recent Developments
  55. 6.10 Shanghai Henlius
  56. 6.10.1 Shanghai Henlius Company Information
  57. 6.10.2 Shanghai Henlius Business Overview
  58. 6.10.3 Shanghai Henlius Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Shanghai Henlius Biosimilars Drug Product Portfolio
  60. 6.10.5 Shanghai Henlius Recent Developments
  61. 6.11 Luye Pharma
  62. 6.11.1 Luye Pharma Company Information
  63. 6.11.2 Luye Pharma Business Overview
  64. 6.11.3 Luye Pharma Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Luye Pharma Biosimilars Drug Product Portfolio
  66. 6.11.5 Luye Pharma Recent Developments
  67. 6.12 Jiangsu Hengrui
  68. 6.12.1 Jiangsu Hengrui Company Information
  69. 6.12.2 Jiangsu Hengrui Business Overview
  70. 6.12.3 Jiangsu Hengrui Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Jiangsu Hengrui Biosimilars Drug Product Portfolio
  72. 6.12.5 Jiangsu Hengrui Recent Developments
  73. 6.13 Innovent Biologics
  74. 6.13.1 Innovent Biologics Company Information
  75. 6.13.2 Innovent Biologics Business Overview
  76. 6.13.3 Innovent Biologics Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Innovent Biologics Biosimilars Drug Product Portfolio
  78. 6.13.5 Innovent Biologics Recent Developments
  79. 6.14 Geropharm
  80. 6.14.1 Geropharm Company Information
  81. 6.14.2 Geropharm Business Overview
  82. 6.14.3 Geropharm Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Geropharm Biosimilars Drug Product Portfolio
  84. 6.14.5 Geropharm Recent Developments
  85. 6.15 Gan&Lee
  86. 6.15.1 Gan&Lee Company Information
  87. 6.15.2 Gan&Lee Business Overview
  88. 6.15.3 Gan&Lee Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Gan&Lee Biosimilars Drug Product Portfolio
  90. 6.15.5 Gan&Lee Recent Developments
  91. 6.16 Dr Reddy’s
  92. 6.16.1 Dr Reddy’s Company Information
  93. 6.16.2 Dr Reddy’s Business Overview
  94. 6.16.3 Dr Reddy’s Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Dr Reddy’s Biosimilars Drug Product Portfolio
  96. 6.16.5 Dr Reddy’s Recent Developments
  97. 6.17 Celltrion
  98. 6.17.1 Celltrion Company Information
  99. 6.17.2 Celltrion Business Overview
  100. 6.17.3 Celltrion Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Celltrion Biosimilars Drug Product Portfolio
  102. 6.17.5 Celltrion Recent Developments
  103. 6.18 Celgen Biopharma
  104. 6.18.1 Celgen Biopharma Company Information
  105. 6.18.2 Celgen Biopharma Business Overview
  106. 6.18.3 Celgen Biopharma Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Celgen Biopharma Biosimilars Drug Product Portfolio
  108. 6.18.5 Celgen Biopharma Recent Developments
  109. 6.19 Bio-Thera
  110. 6.19.1 Bio-Thera Company Information
  111. 6.19.2 Bio-Thera Business Overview
  112. 6.19.3 Bio-Thera Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Bio-Thera Biosimilars Drug Product Portfolio
  114. 6.19.5 Bio-Thera Recent Developments
  115. 6.20 Biocon
  116. 6.20.1 Biocon Company Information
  117. 6.20.2 Biocon Business Overview
  118. 6.20.3 Biocon Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Biocon Biosimilars Drug Product Portfolio
  120. 6.20.5 Biocon Recent Developments
  121. 6.21 3SBIO
  122. 6.21.1 3SBIO Company Information
  123. 6.21.2 3SBIO Business Overview
  124. 6.21.3 3SBIO Biosimilars Drug Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 3SBIO Biosimilars Drug Product Portfolio
  126. 6.21.5 3SBIO Recent Developments
7 North America
  1. 7.1 North America Biosimilars Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Biosimilars Drug Market Size by Country (2021-2026)
  3. 7.3 North America Biosimilars Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Biosimilars Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Biosimilars Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Biosimilars Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Biosimilars Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Biosimilars Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Biosimilars Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Biosimilars Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Biosimilars Drug Market Size by Country (2021-2026)
  3. 10.3 South America Biosimilars Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Biosimilars Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Biosimilars Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Biosimilars Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst